Intellipharmaceutics International Inc. (IPCI)

[Amigo Mike]

Fabius,

Yes I saw that too, i.e. $2.7 billion market size in pipeline docs but far far less in the PR ($591 million).

If that is true and not a typo it goes to show you what I have been talking about that IPCI's slice of these ANDAs is almost always diminishing. Hence when there are valuation questions. See Focalin prior sales and in most recent qtr as easy example.

Definitely nice to get this approval but no partner = no revenue to IPCI for now. Hopefully it is not another Keppra and there is a partner announcement quickly. And given the recent note on bonuses related to Keppra, Glucophage is much bigger ...... did mgmt. do it again ?

Amigo Mike